Patrick Hopkinson | Executive Director, WWHEOR Markets
Bristol Myers Squibb

Patrick Hopkinson, Executive Director, WWHEOR Markets, Bristol Myers Squibb

Patrick is Executive Director World Wide Health Economics and Outcomes Research (WWHEOR) Markets at Bristol Myers Squibb. He leads the team responsible for supporting country HTA submissions and access. He is responsible for all countries outside of the US. Patrick also leads WWHEOR HTA Policy initiatives. He is a member of EFPIA HTA Task force. Before this role Patrick led the BMS UK&Ireland Market Access function responsible for the HTA submissions to NICE, SMC, AWMSG and NCPE. He also led the BMS HTA Policy strategy with the ABPI. Previously Patrick worked at GSK for 14 years in Sales & Marketing, HEOR and Market Access. He was an Oncology Pharmacist for 8 years before joining GSK. He holds a Diploma in Clinical Pharmacy, a Masters in Health Economics and an MBA from Henley Management School, UK.


Day 1 Orphan 14th Nov @ 17:00

Assessing the Value of Immunotherapy (IO): Challenges and Opportunities

  • How this has affected future plans with increasingly more treatments tailored for smaller populations

Day 1 Orphan 14th Nov @ 17:25

Discussion: Examining the challenges of valuation from payers and HTAs

  • Pricing and evaluating orphan drugs - present and future
  • What are the interests of payers and HTA bodies when considering how to improve access to rare disease therapies?
  • How will the increase of cancer, biosimilars and gene therapies change the pricing and access?

back to speakers